Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N S Callander

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Seminars in Hematology|August 7, 2001
Myeloma bone diseaseN S Callander, G D Roodman
Cancer|September 1, 1992
Immunohistochemical identification of tissue factor in solid tumorsN S Callander, N Varki, L V Rao
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|August 28, 1998
Treatment of oral chronic graft-versus-host disease with PUVA therapy: case report and literature reviewS W Redding, N S Callander, C W Haveman, et al.
The Journal of Biological Chemistry|January 15, 1992
Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor XaN S Callander, L V Rao, O Nordfang, et al.
Oncogene|October 12, 2010
Negative regulation of the tumor suppressor p53 gene by microRNAsM Kumar, Z Lu, A A L Takwi, et al.
Bone Marrow Transplantation|October 1, 1992
Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patientsJ H Essell, J M Thompson, G S Harman, et al.
Bone Marrow Transplantation|January 26, 2006
Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myelomaJ I Arango, A Restrepo, D L Schneider, et al.
Blood Cancer Journal|September 3, 2016
Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: long-term follow-upN Biran, S Jacobus, D H Vesole, et al.
Bone Marrow Transplantation|September 18, 2002
Performance of a hybrid central venous catheter utilized for both peripheral blood stem cell harvest and transplant support of patients undergoing autologous peripheral blood stem cell transplantationA Restrepo, P Devore, C E Encarnación, et al.
Bone Marrow Transplantation|August 25, 2015
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantationG L Uy, L J Costa, P N Hari, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Seminars in Hematology|August 7, 2001
Myeloma bone diseaseN S Callander, G D Roodman
Cancer|September 1, 1992
Immunohistochemical identification of tissue factor in solid tumorsN S Callander, N Varki, L V Rao
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|August 28, 1998
Treatment of oral chronic graft-versus-host disease with PUVA therapy: case report and literature reviewS W Redding, N S Callander, C W Haveman, et al.
The Journal of Biological Chemistry|January 15, 1992
Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor XaN S Callander, L V Rao, O Nordfang, et al.
Oncogene|October 12, 2010
Negative regulation of the tumor suppressor p53 gene by microRNAsM Kumar, Z Lu, A A L Takwi, et al.
Bone Marrow Transplantation|October 1, 1992
Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patientsJ H Essell, J M Thompson, G S Harman, et al.
Bone Marrow Transplantation|January 26, 2006
Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myelomaJ I Arango, A Restrepo, D L Schneider, et al.
Blood Cancer Journal|September 3, 2016
Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: long-term follow-upN Biran, S Jacobus, D H Vesole, et al.
Bone Marrow Transplantation|September 18, 2002
Performance of a hybrid central venous catheter utilized for both peripheral blood stem cell harvest and transplant support of patients undergoing autologous peripheral blood stem cell transplantationA Restrepo, P Devore, C E Encarnación, et al.
Bone Marrow Transplantation|August 25, 2015
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantationG L Uy, L J Costa, P N Hari, et al.
Pageof 1